Pressure BioSciences' Q2 Revenues Climb 70 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Pressure BioSciences today said that revenues for the second quarter increased 70 percent year over year, driven by grant revenues.

The South Easton, Mass.-based firm recorded $324,908 in revenues for the three months ended June 30. Revenues generated by its Pressure Cycling Technology came in at $224,384, up 18 percent from $190,686 a year ago. The company also posted $100,524 in grant revenues compared to none a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.